injectible lani, page-2

the next biotech like biota to go up should very well be Sirtex = SRX. There are at least 2 catalysts coming. The first is the Sir Spheres research paper is going to be released into US media and journals and publications from the European studies into the US demonstrating the effectiveness of Sir Spheres in combination therapy. The next is that Sirtex which is a small 82 million USD market cap company is going to appear and present and sponsor with several large 100 Billion market cap. US pharmas which include Genentech, Aventis and Pfizer demonstrating the effectiveness in trial results of Sir Spheres with each of these companies chemotherapy drugs to treat liver cancer and new tumors that have metastisized to the liver. This is a very big Billions dollar market potential for the Sir Spheres from Sirtex . The appropriate links are below.
http://www.touchbriefings.com/pdf/1432/Kennedy.pdf
and
http://www.cancerconferences.com/
For the latter link see the 4th international Congress